欢迎访问西安瑞禧生物技术有限公司官方网站

图片名

全国订购热线:
18966759382

首页 > 定制合成 > 小分子PEG

小分子PEG
小分子PEG 嵌段共聚物 纳米材料 糖化学 荧光量子点 其他产品

IR-825, CAS: 1558079-49-4,ICG吲哚菁绿

作者:瑞禧生物 发布时间:2022-11-11 16:06:02 次浏览

IR-825, CAS: 1558079-49-4,ICG吲哚菁绿
英文名称:3-[(4-Carboxyphenyl)methyl]-2-[2-[3-[2-[3-[(4-carboxyphenyl)methyl]-1,3-dihydro-1,1-dimethyl-2H-benz[e]indol-2-ylidene]ethylidene]-2-chloro-1-cyclohexen-1-yl]ethenyl]-1,1-dimethyl-1H-benz[e]indolium产品
名称:3-[(4-羧基苯基)甲基]-2-[2-[3-[2-[3-[(4-羧基苯基)甲基]-1,3-二氢-1,1-二甲基-2H-苯并[e]吲哚-2-亚基]亚乙基]-2-氯-1-环己烯-1-基]乙烯基]-1,1-二甲基-1H-苯并[e]吲哚鎓分子式:C54H48ClN2O4分子量:824.42CAS:1558079-49-4结构式: IR-825, CAS: 1558079-49-4,ICG吲哚菁绿IR-825, after encapsulated into nanoparticles may be useful for cancer photothermal and photodynamic therapy. IR-825 nanoparticles showed pH-dependent fluorescence emission and excellent near-infrared (NIR) irradiation of cancer cells targeted in vitro to provide cytotoxicity. IR-825 nanoparticles showed efficient tumor homing together with rapid renal excretion behaviors, as revealed by MR imaging and confirmed by biodistribution measurement. Notably, when irradiated with an 808 nm laser, tumors on mice with IR-825 nanoparticle injection are compley eliminated without recurrence within 60 days, demonstrating the high efficacy of photothermal therapy.